In vitro labeling of glioma cells with gadofluorine M enhances T 1 visibility without affecting glioma cell growth or motility

Magnetic Resonance in Medicine

Volumn 59, Issue 5, 2008, Pages 1014-1020

  Nolte, Ingo S ^a   Gungor, Sevil ^a   Erber, Ralf ^a   Plaxina, Elena ^a   Scharf, Johann ^a   Misselwitz, Bernd ^b   Gerigk, Lars ^a   Przybilla, Heike ^a   Groden, Christoph ^a   Brockmann, Marc A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Gadofluorine; Glioma cell; In vitro

Indexed keywords

CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELLS; FLUORESCENCE MICROSCOPY; IRON OXIDES; MAMMALS; TUMORS; VISIBILITY;

CELL CULTURE MEDIUMS; CONFOCAL LASER FLUORESCENCE MICROSCOPY; GADOFLUORINE; GLIOMA CELLS; IN-VITRO; INTRACELLULAR UPTAKE; IRON OXIDE PARTICLES; SUSCEPTIBILITY ARTIFACTS;

MOLECULAR BIOLOGY;

FLUORINE DERIVATIVE; GADOFLUORINE M; IRON OXIDE;

ARTICLE; ARTIFACT REDUCTION; CELL GROWTH; CELL LABELING; CELL MIGRATION; CELL MOTILITY; CONFOCAL LASER MICROSCOPY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; GLIOMA CELL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; PHAGOCYTOSIS;

EID: 42549135455     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21503     Document Type: Article

References (32)

1. 1 Misselwitz B. MR contrast agents in lymph node imaging. Eur J Radiol 2006 ; 58: 375–382.
2. 2 Misselwitz B, Platzek J, Raduchel B, Oellinger JJ, Weinmann HJ. Gadofluorine 8: initial experience with a new contrast medium for interstitial MR lymphography. Magma 1999 ; 8: 190–195.
3. 3 Staatz G, Nolte‐Ernsting CC, Adam GB, Grosskortenhaus S, Misselwitz B, Bucker A, Gunther RW. Interstitial T1‐weighted MR lymphography: lipophilic perfluorinated gadolinium chelates in pigs. Radiology 2001 ; 220: 129–134.
4. 4 Barkhausen J, Ebert W, Heyer C, Debatin JF, Weinmann HJ. Detection of atherosclerotic plaque with Gadofluorine‐enhanced magnetic resonance imaging. Circulation 2003 ; 108: 605–609.
5. 5 Bendszus M, Stoll G. Technology insight: visualizing peripheral nerve injury using MRI. Nat Clin Pract Neurol 2005 ; 1: 45–53.
6. 6 Bendszus M, Wessig C, Schutz A, Horn T, Kleinschnitz C, Sommer C, Misselwitz B, Stoll G. Assessment of nerve degeneration by gadofluorine M‐enhanced magnetic resonance imaging. Ann Neurol 2005 ; 57: 388–395.
7. 7 Koktzoglou I, Harris KR, Tang R, Kane BJ, Misselwitz B, Weinmann HJ, Lu B, Nagaraj A, Roth SI, Carroll TJ, McPherson DD, Li D. Gadofluorine‐enhanced magnetic resonance imaging of carotid atherosclerosis in Yucatan miniswine. Invest Radiol 2006 ; 41: 299–304.
8. 8 Misselwitz B, Platzek J, Weinmann HJ. Early MR lymphography with gadofluorine M in rabbits. Radiology 2004 ; 231: 682–688.
9. 9 Shimada M, Yoshikawa K, Suganuma T, Kayanuma H, Inoue Y, Ito K, Senoo A, Hayashi S. Interstitial magnetic resonance lymphography: comparative animal study of gadofluorine 8 and gadolinium diethylenetriamine‐pentaacetic acid. J Comput Assist Tomogr 2003 ; 27: 641–646.
10. 10 Sirol M, Itskovich VV, Mani V, Aguinaldo JG, Fallon JT, Misselwitz B, Weinmann HJ, Fuster V, Toussaint JF, Fayad ZA. Lipid‐rich atherosclerotic plaques detected by gadofluorine‐enhanced in vivo magnetic resonance imaging. Circulation 2004 ; 109: 2890–2896.
11. 11 Stoll G, Wessig C, Gold R, Bendszus M. Assessment of lesion evolution in experimental autoimmune neuritis by gadofluorine M‐enhanced MR neurography. Exp Neurol 2006 ; 197: 150–156.
12. 12 Brockmann MA, Ulbricht U, Gruner K, Fillbrandt R, Westphal M, Lamszus K. Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor‐associated growth factors. Neurosurgery 2003 ; 52: 1391–1399 ; discussion 1399.
13. 13 Brockmann MA, Papadimitriou A, Brandt M, Fillbrandt R, Westphal M, Lamszus K. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor‐antagonist NK4. Clin Cancer Res 2003 ; 9: 4578–4585.
14. 14 Brockmann MA, Westphal M, Lamszus K. Improved method for the intracerebral engraftment of tumour cells and intratumoural treatment using a guide screw system in mice. Acta Neurochir (Wien) 2003 ; 145: 777–781 ; discussion 781.
15. 15 Enochs WS, Harsh G, Hochberg F, Weissleder R. Improved delineation of human brain tumors on MR images using a long‐circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 1999 ; 9: 228–232.
16. 16 Anderson SA, Glod J, Arbab AS, Noel M, Ashari P, Fine HA, Frank JA. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005 ; 105: 420–425.
17. 17 Frank JA, Anderson SA, Kalsih H, Jordan EK, Lewis BK, Yocum GT, Arbab AS. Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy 2004 ; 6: 621–625.
18. 18 Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004 ; 104: 1217–1223.
19. 19 Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 2003 ; 63: 8122–8125.
20. 20 Moore A, Weissleder R, Bogdanov A Jr. Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages. J Magn Reson Imaging 1997 ; 7: 1140–1145.
21. 21 Nolte I, Vince GH, Maurer M, Herbold C, Goldbrunner R, Solymosi L, Stoll G, Bendszus M. Iron particles enhance visualization of experimental gliomas with high‐resolution sonography. AJNR Am J Neuroradiol 2005 ; 26: 1469–1474.
22. 22 Bulte JW, Zhang S, van Gelderen P, Herynek V, Jordan EK, Duncan ID, Frank JA. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 1999 ; 96: 15256–15261.
23. 23 Moore A, Basilion JP, Chiocca EA, Weissleder R. Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta 1998 ; 1402: 239–249.
24. 24 Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000 ; 6: 351–355.
25. 25 Riviere C, Boudghene FP, Gazeau F, Roger J, Pons JN, Laissy JP, Allaire E, Michel JB, Letourneur D, Deux JF. Iron oxide nanoparticle‐labeled rat smooth muscle cells: cardiac MR imaging for cell graft monitoring and quantitation. Radiology 2005 ; 235: 959–967.
26. 26 Arbab AS, Yocum GT, Wilson LB, Parwana A, Jordan EK, Kalish H, Frank JA. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging 2004 ; 3: 24–32.
27. 27 Botnar RM, Buecker A, Wiethoff AJ, Parsons EC Jr, Katoh M, Katsimaglis G, Weisskoff RM, Lauffer RB, Graham PB, Gunther RW, Manning WJ, Spuentrup E. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin‐binding molecular magnetic resonance contrast agent. Circulation 2004 ; 110: 1463–1466.
28. 28 Spuentrup E, Katoh M, Wiethoff AJ, Parsons EC Jr, Botnar RM, Mahnken AH, Gunther RW, Buecker A. Molecular magnetic resonance imaging of pulmonary emboli with a fibrin‐specific contrast agent. Am J Respir Crit Care Med 2005 ; 172: 494–500.
29. 29 Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, Wickline SA, Lanza GM. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001 ; 104: 1280–1285.
30. 30 Henning TD, Saborowski O, Golovko D, Boddington S, Bauer JS, Fu Y, Meier R, Pietsch H, Sennino B, McDonald DM, Daldrup‐Link HE. Cell labeling with the positive MR contrast agent Gadofluorine M. Eur Radiol 2007 ; 17: 1226–1234.
31. 31 Brockmann MA, Kemmling A, Groden C. Current issues and perspectives in small rodent magnetic resonance imaging using clinical MRI scanners. Methods 2007 ; 43: 79–87.
32. 32 Brockmann MA, Ulmer S, Leppert J, Nadrowitz R, Wuestenberg R, Nolte I, Petersen D, Groden C, Giese A, Gottschalk S. Analysis of mouse brain using a clinical 1.5 Tesla scanner and a standard small loop surface coil. Brain Res 2006 ; 1068: 138–142.